Archive | Melanoma In The News

Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma

The combination of standard-dose pembrolizumab with four reduced doses of ipilimumab followed by standard-dose pembrolizumab had a manageable safety profile and antitumor activity in patients with advanced melanoma, according to the results of the phase Ib KEYNOTE-029 study published in Lancet Oncology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

The Cancer Genes Needed for Immunotherapy Response

Immune checkpoint inhibitor antibodies are a relatively new class of cancer drugs that are now approved to treat patients with late-stage melanoma and those with certain lung, bladder, head and neck, kidney, and other types of late-stage cancers.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Scientists Discover Dozens of New Genes that Create T-Cell Resistant Cancer

Source: New York University, August 2017 A team of scientists has uncovered dozens of novel genes involved in resistance to therapies that harness the immune system to fight cancer. The findings, which appear in the journal Nature, enhance our understanding of why some cancers are resistant to immunotherapy. “We cast a wide, deep net and […]

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Vitamin B may help prevent melanoma

Vitamin B3 therapy may help prevent melanoma in those at greatest risk of developing the deadly skin cancer.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories